Literature DB >> 19794363

Depressive disorders and comorbidity: somatic illness vs. side effect.

Suzana Uzun1, Oliver Kozumplik, Radmila Topić, Miro Jakovljević.   

Abstract

BACKGROUND: The rate of comorbid depression and medical illness varies from 10 to 40%. Patients with depressive disorder compared to general population more often have cardiovascular and cerebrovascular disorders, diabetes, irritable bowel syndrome, and some types of tumor. Side effects of mental health medications may appear in a form that is very similar to clinical presentation of somatic illness. Side effects that appear during treatment of depressive disorder, e. g. cardiovascular, gastrointestinal, movement disorders, etc., may provoke certain diagnostic issues regarding origin of such symptoms (somatic illness vs. side effect). The aim of this article is to review literature regarding comorbidity of depressive disorder and somatic illness and to point at possible diagnostic problems in differentiating comorbid somatic illness and side effects of antidepressants. CONTENT ANALYSIS OF LITERATURE: Literature research included structured searches of Medline and other publications on the subject of comorbidity of depressive disorder and somatic disorders and possible diagnostic problems in differentiating comorbid somatic illnesses from side effects of antidepressants.
CONCLUSION: Comorbidity between depressive disorder and various somatic disorders appears often. Investigations suggest that depressive disorder is underdiagnosed in such cases. Side effects of antidepressants are sometimes very hard to differentiate from symptoms of somatic illness, which may lead to diagnostic issues. Bearing in mind frequent comorbidity between of depressive and somatic disorders, early recognition of such comorbidity is important, as well as the selection of antidepressant. It is important to recognize depressive disorder in patients with somatic illnesses, as well as somatic illness in patients primarily treated because of depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794363

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  7 in total

1.  Profiles Associated Respectively with Substance Dependence Only, Mental Disorders Only and Co-occurring Disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jean Caron
Journal:  Psychiatr Q       Date:  2015-09

2.  Disease Trajectories for Hidradenitis Suppurativa in the Danish Population.

Authors:  Rune Kjærsgaard Andersen; Isabella Friis Jørgensen; Roc Reguant; Gregor Borut Ernst Jemec; Søren Brunak
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

3.  Screening Depressive Symptoms and Incident Major Depressive Disorder Among Chinese Community Residents Using a Mobile App-Based Integrated Mental Health Care Model: Cohort Study.

Authors:  Huimin Zhang; Yuhua Liao; Lan Guo; Ciyong Lu; Xue Han; Beifang Fan; Yifeng Liu; Leanna M W Lui; Yena Lee; Mehala Subramaniapillai; Lingjiang Li; Roger S McIntyre
Journal:  J Med Internet Res       Date:  2022-05-20       Impact factor: 7.076

4.  The pattern of physical comorbidity and the psychosocial determinants of depression: a prospective cohort study on a representative sample of family practice attendees in Slovenia.

Authors:  Polona Selič; Igor Svab; Janez Rifel; Danica Rotar Pavlič; Anja Cerne; Michael King; Irwin Nazareth
Journal:  Ment Health Fam Med       Date:  2011-09

5.  Co-morditities of environmental diseases: A common cause.

Authors:  Harold I Zeliger
Journal:  Interdiscip Toxicol       Date:  2014-12-30

6.  Improving detection of mental health problems in community settings in Nepal: development and pilot testing of the community informant detection tool.

Authors:  Prasansa Subba; Nagendra P Luitel; Brandon A Kohrt; Mark J D Jordans
Journal:  Confl Health       Date:  2017-11-20       Impact factor: 2.723

7.  Self-Harm Thoughts Postpartum as a Marker for Long-Term Morbidity.

Authors:  Stavros I Iliadis; Alkistis Skalkidou; Hanna Ranstrand; Marios K Georgakis; Cathrine Axfors; Fotios C Papadopoulos
Journal:  Front Public Health       Date:  2018-02-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.